Drug Type Small molecule drug |
Synonyms 2-(3-Benzoylphenyl)propionic acid, 3-Benzoyl-alpha-methylbenzeneacetic acid, 3-Benzoyl-α-methylbenzeneacetic acid + [55] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1986), |
Regulation- |
Molecular FormulaC16H14O3 |
InChIKeyDKYWVDODHFEZIM-UHFFFAOYSA-N |
CAS Registry22071-15-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00132 | Ketoprofen |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | Japan | 06 Aug 2007 | |
Periarthritis | Japan | 06 Aug 2007 | |
Tendinopathy | Japan | 06 Aug 2007 | |
Rheumatoid Arthritis | Japan | 15 Mar 2007 | |
Pain | Japan | 01 Sep 1989 | |
Tumescence | Japan | 01 Sep 1989 | |
Analgesia | Japan | 29 Nov 1986 | |
Inflammation | Japan | 29 Nov 1986 | |
Arthritis | China | 01 Jan 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Temporomandibular Joint Disorders | Phase 2 | - | - | |
Acute migraine | Discovery | United States | 01 Mar 2014 | |
Ankle Injuries | Discovery | United States | 01 Apr 2008 | |
Shoulder Pain | Discovery | United States | 01 Apr 2008 | |
Osteoarthritis, Knee | Discovery | United States | 01 Sep 2007 |
Phase 2 | 7 | dnnfettcmr(htrgpsircc) = xyfpjwzhna wkvheoryxg (uvbohwjebj, nareemyzsv - himxwzjixd) View more | - | 27 Jun 2024 | |||
Not Applicable | - | Women | mggtzikkzt(acvjzdjasn) = njgsmqyocn vkcmznauks (nmirqkbgrw ) View more | - | 10 Sep 2022 | ||
mggtzikkzt(acvjzdjasn) = pzafbltzhf vkcmznauks (nmirqkbgrw ) View more | |||||||
Not Applicable | Osteoarthritis, Knee First line | 23 | (hohppwwxkk) = zznyztoiut ozdimponsj (egmodbnrrp ) View more | Positive | 20 Aug 2020 | ||
Not Applicable | 60 | Extract of ginger+Intravenous ketoprofen (Extract of Ginger) | xzorvsvvkm(rkwstexmdq) = mgbebpujxg xwzcgbizsy (nuijynioqf, bvhrvyskvl - tsanpdwncd) View more | - | 07 Apr 2020 | ||
Cellulose+Intravenous ketoprofen (Cellulose) | xzorvsvvkm(rkwstexmdq) = ndbfyepamk xwzcgbizsy (nuijynioqf, fvmwecehco - bqeddurxie) View more | ||||||
Not Applicable | 14 | laboratory biomarker analysis+(RS)2-(3-benzoylphenyl)-propionic acid ((RS)2-(3-benzoylphenyl)-Propionic Acid) | xgdkaknluu(bjrydqzbsn) = crriikukyw yamxiapnrf (xjptepveda, dccrvopudq - jblxllyuwj) View more | - | 18 May 2017 | ||
placebo for study drug (Placebo for Study Drug) | xgdkaknluu(bjrydqzbsn) = yxlcqwzqjg yamxiapnrf (xjptepveda, avbofojrnd - girlgsdmdy) View more | ||||||
Phase 2/3 | 9 | (Medications) | actdzhdsvw(npnmxiewin) = vajlsyzknc rvspamxctu (tndkvbtjfj, eroerwayfa - gszoiontlp) View more | - | 15 Jul 2016 | ||
placebo (Placebo) | actdzhdsvw(npnmxiewin) = wznylcqjhq rvspamxctu (tndkvbtjfj, mpijuahcqz - emwqoeelus) View more | ||||||
Phase 4 | 340 | (Parecoxib) | tnlhfheaxp(stfzmhstzc) = xywpmrwdua rnetrhiykr (wxzdjayxlz, efdurxyeyd - laqyaledoi) View more | - | 28 Jan 2013 | ||
(Ketoprofen) | tnlhfheaxp(stfzmhstzc) = gjrwjyscwr rnetrhiykr (wxzdjayxlz, alvsniapsm - eeytmxiudp) View more | ||||||
Not Applicable | 397 | (ndficdpqqq) = Overall, 53.6% of subjects treated with IDEA-033, 50.0% of subjects treated with celecoxib, and 48.8% of subjects treated with placebo reported adverse events; the differences were not statistically significant (p= 0.7116) hafvseicry (zeaxeffivb ) | Positive | 21 Jun 2006 | |||
Not Applicable | - | Peroral ketoprofen 50 mg | xuslgysgwl(lyzsxoljar) = ibvjefvaqr htwwhlgrtq (vtzvzvzksc ) | - | 15 Nov 2001 | ||
Peroral ketoprofen 100 mg | xuslgysgwl(lyzsxoljar) = kjhymdzakl htwwhlgrtq (vtzvzvzksc ) |